Keyphrases
3-group
16%
Adaptive Immune Response
16%
Anti-spike IgG Antibody
66%
Antibody Concentration
33%
Baseline Concentration
16%
C-reactive Protein
33%
Chemokines
50%
Clinical History
16%
Clinical Parameters
66%
Commercial ELISAs
16%
Confidence Interval
33%
COVID-19
100%
COVID-19 Outcomes
16%
COVID-19 Patients
16%
Creatinine
33%
Cytokine Factors
33%
Cytokine Profile
100%
D-dimer
33%
Disease Severity
16%
Expression Profile
16%
Fatal COVID-19
16%
Fatal Outcome
50%
Feedback Loop
16%
Granulocyte Colony-stimulating Factor (G-CSF)
66%
Growth Factors
33%
Hazard Ratio
33%
Hemoglobin
33%
Hospitalization
16%
Hospitalized COVID-19 Patients
33%
IL-12p70
16%
Infected Patients
16%
Inflammation
16%
Inflammatory Cytokines
16%
Information Parameters
16%
Innate Immune Cells
16%
Interleukin-1 Receptor Antagonist (IL-1Ra)
33%
Interleukin-10
16%
Interleukin-15 (IL-15)
66%
Interleukin-5 (IL-5)
33%
Interleukin-6
66%
Interleukin-8
66%
Laboratory Confirmation
16%
Lima
16%
Logistic Regression
16%
Longitudinal Analysis
33%
Longitudinal Samples
16%
MIP-1b
33%
Moderate Disease
16%
Monocyte Chemoattractant protein-1 (MCP-1)
100%
Multivariable
33%
Neutrophil-lymphocyte
33%
Novel Criterion
33%
Obesity
16%
Patient Death
16%
Patient Discharge
16%
Patient Information
16%
Patient Outcomes
16%
Patient Stratification
16%
Peripheral Blood
16%
Peru
16%
Peruvian
100%
Protein Dimerization
33%
Quantitative Suspension Array Technology
33%
Risk Factors
16%
SARS-CoV-2 Infection
16%
Segmented Neutrophils
16%
Serum Samples
16%
Severe Disease
33%
Univariate Analysis
16%
Worse Prognosis
100%
Immunology and Microbiology
Immunoglobulin G
22%
Interleukin 5
22%
Interleukin 8
44%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin G
33%
Interleukin 10
16%
Interleukin 5
33%